SNYRQ on OTC

Synergy CHC Corp.

American medicinal chemicals and botanical products company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with C21 Investments Inc., Leef Brands Inc. or CYANOTECH CORP, or pick any stock.

  • TickerSNYRQ on OTC1
  • IndustryMedicinal Chemicals & Botanical Products1
  • HeadquartersWestbrook, Maine1
  • Incorporated inNV2
  • Business address865 Spring Street, Westbrook, Me 040922
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Website: Our FOCUSfactor website helps to educate and inform consumers on our line of products. The website also serves as a direct-to-consumer sales channel for most FOCUSfactor products.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

66.8%Gross margin4
-27.8%Operating margin4
-40.6%Net margin4
-12.8%Revenue growth, 20254

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Retail brought in 67% of the revenue Synergy CHC Corp. broke down this way in fiscal 2025.

  1. Retail$22.2M467%down 16% from 2024
  2. Online$8.1M424%down 3% from 2024
  3. License Revenue$2.9M49%
Products and services by year
Products and services20242025
Retail$26.5M$22.2M
Online$8.4M$8.1M
License Revenue$2.9M

Business segments

Nutraceuticals brought in 98% of the revenue Synergy CHC Corp. broke down this way in fiscal 2025.

  1. Nutraceuticals$29.7M498%down 11% from 2024
  2. Beverages$631.3K42%down 56% from 2024
  3. Consumer goods$18.0K40%up 6% from 2024
Business segments by year
Business segments20242025
Nutraceuticals$33.4M$29.7M
Beverages$1.4M$631.3K
Consumer goods$16.9K$18.0K

Regions

United States brought in 90% of the revenue Synergy CHC Corp. broke down this way in fiscal 2025.

  1. United States$27.3M490%down 11% from 2024
  2. Canada$2.4M48%down 38% from 2024
  3. M X$623.7K42%up 17043% from 2024
  4. Other$20.7K40%down 72% from 2024
Regions by year
Regions20242025
United States$30.8M$27.3M
Canada$3.9M$2.4M
M X$3.6K$623.7K
Other$73.0K$20.7K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue33¢$10.1M
  • Other costs66¢$20.2M
  • Income tax0¢$117.5K

Out of $30.4M in revenue.4 The company lost money this year.

Financial statements

Revenue564$30.4M in 2025−10% since 2018
0$20.0M$40.0M$60.0M2018: $33.8M$33.8M20182019: $29.4M$29.4M2019−13%2023: $42.8M$42.8M2023+46%2024: $34.8M$34.8M2024−19%2025: $30.4M$30.4M2025−13%
Gross profit564$20.3M in 2025−11% since 2018
0$10.0M$20.0M$30.0M$40.0M2018: $22.8M$22.8M20182019: $20.2M$20.2M2019−11%2023: $32.1M$32.1M2023+59%2024: $23.6M$23.6M2024−26%2025: $20.3M$20.3M2025−14%
Operating income564-$8.5M in 2025+72% since 2018
-$10.0M-$5.0M0$5.0M$10.0M$15.0M2018: -$4.9M-$4.9M20182019: -$8.0M-$8.0M2019+62%2023: $10.8M$10.8M20232024: $5.8M$5.8M2024−46%2025: -$8.5M-$8.5M2025
Net income564-$12.3M in 2025+100% since 2018
-$15.0M-$10.0M-$5.0M0$5.0M$10.0M2018: -$6.2M-$6.2M20182019: -$9.2M-$9.2M2019+49%2023: $6.3M$6.3M20232024: $2.1M$2.1M2024−66%2025: -$12.3M-$12.3M2025

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Revenue$30.4M$34.8M
Cost of sales$10.1M$11.2M
Gross Profit$20.3M$23.6M
Selling and marketing$13.1M$13.0M
General and administrative$8.8M$4.7M
Reserve for bad debts$6.7M
Depreciation and amortization$133.3K$133.3K
Total operating expenses$28.8M$17.8M
(Loss) Income from operations-$8.5M$5.8M
Other income-$510.5K
Interest income-$15.1K-$1.5K
Interest expense$5.9M$4.1M
Gain on settlement of notes payable-$2.2M
Remeasurement loss (gain) on translation of foreign subsidiary$14.8K-$19.0K
Total other expenses$3.8M$3.6M
Net (loss) income before income taxes-$12.2M$2.2M
Income tax expense$117.5K$102.1K
Net (loss) income-$12.3M$2.1M
Net (loss) income per share basic (in Dollars per share)-$1.27$0.28
Net (loss) income per share - diluted (in Dollars per share)-$1.27$0.28
Basic (in Shares)9.7M shares7.6M shares
Diluted (in Shares)9.7M shares7.6M shares
Foreign currency translation adjustment-$106.5K$54.7K
Comprehensive (loss) income-$12.4M$2.2M

Compare Synergy CHC Corp. with another company

Leadership

Who has led Synergy CHC Corp., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (8)

Former names

  • Synergy Strips Corp.May 7, 2014 to Aug 6, 20152
  • Oro Capital Corporation, Inc.Nov 21, 2012 to Apr 24, 20142

Filings

123 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 25 major events, 25 insider forms, 4 large holders, 62 other. The latest 20:

  1. Sep 16, 20268-K CURRENT REPORT EDGAR
  2. Sep 8, 20268-K CURRENT REPORT EDGAR
  3. Aug 26, 20268-K CURRENT REPORT EDGAR
  4. Aug 21, 20268-K CURRENT REPORT EDGAR
  5. Aug 11, 20268-K CURRENT REPORT EDGAR
  6. Jul 29, 20268-K CURRENT REPORT EDGAR
  7. Jul 1, 20264 PRIMARY DOCUMENT EDGAR
  8. Jul 1, 20264 PRIMARY DOCUMENT EDGAR
  9. Jul 1, 20264 PRIMARY DOCUMENT EDGAR
  10. Jun 29, 20268-K CURRENT REPORT EDGAR
  11. May 22, 2026EFFECT EDGAR
  12. May 21, 2026CORRESP EDGAR
  13. May 21, 2026UPLOAD EDGAR
  14. May 18, 20268-K CURRENT REPORT EDGAR
  15. May 15, 2026S-1 REGISTRATION STATEMENT EDGAR
  16. May 14, 20268-K CURRENT REPORT EDGAR
  17. May 14, 202610-Q QUARTERLY REPORT EDGAR
  18. May 11, 20268-K CURRENT REPORT EDGAR
  19. Apr 30, 2026ARS ANNUAL REPORT EDGAR
  20. Apr 30, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR

The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

123 open-market trades by officers, directors and large owners since October 2021: 123 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 30, 2025Ross JackCEO and ChairmanBuy100$3.69$369Form 4
Jul 29, 2025Ross JackCEO and ChairmanBuy250$3.66$915Form 4
Jul 25, 2025Ross JackCEO and ChairmanBuy350$3.90$1.4KForm 4
Jul 24, 2025Ross JackCEO and ChairmanBuy300$3.83$1.1KForm 4
Jul 22, 2025Ross JackCEO and ChairmanBuy300$3.54$1.1KForm 4
Jul 11, 2025Ross JackCEO and ChairmanBuy750$3.20$2.4KForm 4
Jul 10, 2025Ross JackCEO and ChairmanBuy1,400$3.19$4.5KForm 4
Jul 9, 2025Ross JackCEO and ChairmanBuy400$3.15$1.3KForm 4
Jul 8, 2025Ross JackCEO and ChairmanBuy800$3.36$2.7KForm 4
Jul 7, 2025Ross JackCEO and ChairmanBuy700$3.26$2.3KForm 4
Jul 3, 2025Ross JackCEO and ChairmanBuy1,750$3.22$5.6KForm 4
Jul 2, 2025Ross JackCEO and ChairmanBuy3,750$3.23$12.1KForm 4
Jul 1, 2025Ross JackCEO and ChairmanBuy250$3.05$762Form 4
Jun 30, 2025Ross JackCEO and ChairmanBuy2,600$2.69$7.0KForm 4
Jun 27, 2025Ross JackCEO and ChairmanBuy100$2.60$260Form 4
Jun 26, 2025Ross JackCEO and ChairmanBuy650$2.55$1.7KForm 4
Jun 24, 2025Ross JackCEO and ChairmanBuy600$2.63$1.6KForm 4
Jun 23, 2025Ross JackCEO and ChairmanBuy400$2.61$1.0KForm 4
Jun 20, 2025Ross JackCEO and ChairmanBuy10,300$2.60$26.8KForm 4
Jun 18, 2025Ross JackCEO and ChairmanBuy600$2.23$1.3KForm 4

All 123 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Jane Street Group, LLC181,648$36.1K0.0%New
ACT Advisors, LLC.151,840$30.1K0.0%New
XTX Topco Ltd61,270$12.2K0.0%New
Vanguard Capital Management LLC38,909$7.7K0.0%−50,861
Geode Capital Management, LLC32,775$6.5K0.0%+11,377
Vanguard Fiduciary Trust Co16,008$3.2K0.0%−7,141
StoneX Group Inc.15,109$3.0K0.0%New
Ewa, LLC13,727$2.7K0.0%New
Citadel Advisors LLC10,902$2.2K0.0%New
Williams & Novak, LLC10,020$2.0K0.0%−1,925
Tower Research Capital LLC (TRC)3,714$7370.0%+822
Barclays PLC884$1750.0%New
Hrt Financial LP34,035$60.0%New
Virtu Financial LLC18,539$40.0%New

13F reports cover disclosed long positions in U.S. stocks only.